Fortive Corporation acquires Advanced Sterilization Products (ASP) business of Johnson & Johnson
Snapshot
Fortive Corporation acquired Advanced Sterilization Products (ASP) business of Johnson & Johnson for aggregate purchase price of $2.7 billion in April 2019. The transaction was structured as all cash. Advanced Sterilization Products (ASP) business of Johnson & Johnson is a Irvine, California (global operations)-based Advanced Healthcare Solutions business.
- Acquirer
- Fortive Corporation
- Target
- Advanced Sterilization Products (ASP) business of Johnson & Johnson
- Value
- aggregate purchase price of $2.7 billion
- Date
- April 2019
- Type
- carve-out
- Status
- ready
The deal at a glance
About this deal
Fortive Corporation acquired Advanced Sterilization Products (ASP) business of Johnson & Johnson for aggregate purchase price of $2.7 billion, a transaction completed in April 2019, structured as all cash. The deal was a carve-out.
Advanced Sterilization Products (ASP) business of Johnson & Johnson operates in Advanced Healthcare Solutions, is based in Irvine, California (global operations). Advanced Sterilization Products is a global leader in low-temperature terminal sterilization and high-level disinfection used by hospitals to sterilize medical instruments. Acquired from Ethicon, Inc., a subsidiary of Johnson & Johnson, under a Stock and Asset Purchase Agreement covering Principal and Non-Principal Countries.
Adds a recurring-consumable healthcare sterilization platform anchoring Fortive's healthcare segment.
Large installed base with recurring consumable revenue in infection prevention. Advanced Healthcare Solutions
No advisory firms have been disclosed for this transaction.